Host stromal bradykinin B2 receptor signaling facilitates tumor-associated angiogenesis and tumor growth

Cancer Research

Volumn 64, Issue 15, 2004, Pages 5178-5185

  Ikeda, Yasuhiro ^a,b   Hayashi, Izumi ^a,b   Kamoshita, Emi ^a,b   Yamazaki, Akira ^a   Endo, Hirahito ^a   Ishihara, Keiko ^a   Yamashina, Shohei ^b   Tsutsumi, Yoshiaki ^c   Matsubara, Hiroaki ^c   Majima, Masataka ^a,b,d  

^a KITASATO UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

^b KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c KANSAI MEDICAL UNIVERSITY   (Japan)

^d NONE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

3 (6 ACETAMIDO 3 PYRIDYL) N [N [2,4 DICHLORO 3 [(2 METHYL 8 QUINOLINYL)OXYMETHYL]PHENYL] N METHYLAMINOCARBONYLMETHYL]ACRYLAMIDE; BRADYKININ; BRADYKININ B2 RECEPTOR; BRADYKININ B2 RECEPTOR ANTAGONIST; ICATIBANT; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ISOLATION; CONTROLLED STUDY; DRUG RECEPTOR BINDING; FIBROBLAST CULTURE; IMMUNOREACTIVITY; KALLIKREIN KININ SYSTEM; KNOCKOUT MOUSE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SARCOMA; SIGNAL TRANSDUCTION; SOLID TUMOR; STATISTICAL SIGNIFICANCE; STROMA; TUMOR GROWTH; WILD TYPE;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BLOOD VESSELS; CARCINOMA 256, WALKER; FIBROBLASTS; KALLIKREIN-KININ SYSTEM; KININOGENS; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEOVASCULARIZATION, PATHOLOGIC; QUINOLINES; RATS; RATS, INBRED BN; RECEPTOR, BRADYKININ B2; RNA, MESSENGER; SARCOMA 180; SIGNAL TRANSDUCTION; STROMAL CELLS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 3442878400     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-03-3589     Document Type: Article

References (51)

1. Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1995;1:27-31.
2. Griffioen AW, Moiema G. Angiogenesis: potentials for pharmacologic intervention in the treatment of cancer, cardiovascular diseases, and chronic inflammation. Pharmacol Rev 2000;52:237-67.
3. Campochiaro PA. Retinal and choroidal neovascularization. J Cell Physiol 2000;7184:301-10.
4. Koch AE. Angiogenesis. Arthritis Rheum 1998;41:951-62.
5. Weidner N, Folkman J. Tumoral vascularity as a prognostic factor in cancer. Adv Oncol 1996;11:167-90.
6. Weidner N, Semple JP, Welch SVR, Folkman J. Tumor angiogenesis and metastasis: correlation in invasive breast carcinoma. N Engl J Med 1991;324:1-8.
7. Borre M, Offersen BV, Nerstrom B, Overgaard J. Microvessel density predicts survival in prostate cancer patients subjected to watchful waiting. Br J Cancer 1998;78:940-4.
8. Hillen HF, Hak LE, Joosten-Achjanie SR, Arends JW. Microvessel density in unknown primary tumors. Int J Cancer 1997;74:81-5.
9. Nagy JA, Brown LF, Senger DR, et al. Pathogenesis of tumor stroma generation: a critical role for leaky blood vessels and fibrin deposition. Biochim Biophys Acta 1989;948:305-26.
10. Wernert N. The multiple roles of tumour stroma. Virchows Arch 1997;430:433-43.
11. Seljelid R, Jozefowski S, Sveinbjörnsson B. Tumor stroma. Anticancer Res 1999;19:4809-22.
12. Williams CS, Tsujii M, Reese J, Dey SK, DuBois RN. Host cyclooxygenase-2 modulates carcinoma growth. J Clin Investig 2000;105:1589-94.
13. Amano H, Hayashi I, Endo H, et al. Host prostaglandin E(2)-EP3 signaling regulates tumor-associated angiogenesis and tumor growth. J Exp Med 2003;197:221-32.
14. Majima M, Amano H, Hayashi I. Prostanoid receptor signaling relevant to tumor growth and angiogenesis. Trends Pharmacol Sci 2003;24:524-9.
15. Bhoola KD, Figueroa CD, Worthy K. Bioregulation of kinins: kallikreins, kininogens. and kininases. Pharmacol Rev 1992;44:1-80.
16. Katori M, Majima M. Pivotal role of renal kallikrein-kinin system in the development of hypertension and approaches to new drugs based on this relationship. Jpn J Pharmacol 1996;70:95-128.
17. Majima M, Katori M. Approaches to the development of novel antihypertensive drugs: crucial role of the renal kallikrein-kinin system. Trends Pharmacol Sci 1995;16:239-46.
18. Hu DE, Fan TP. [Leu8]des-Arg9-bradykinin inhibits the angiogenic effect of bradykinin and interleukin-1 in rats. Br J Pharmacol 1993;109:14-7.
19. Hayashi T, Amano H, Yoshida S, et al. Suppressed angiogenesis in kininogen-deficiencies. Lab Invest 2002;82:871-80.
20. Ishihara K, Hayashi I, Majima M. A potential role of bradykinin in angiogenesis and growth of S-180 mouse tumors. Jpn J Pharmacol 2001;87:318-26.
21. Matsumura Y, Maruo K, Kimura M, Yamamoto T, Konno T, Maeda H. Kinin-generating cascade in advanced cancer patients and in vitro study. Jpn J Cancer Res 1991;82:732-41.
22. Wu J, Akaike T, Maeda H. Modulation of enhanced vascular permeability in tumors by a bradykinin antagonist, a cyclooxygenase inhibitor, and a nitric oxide scavenger. Cancer Res 1998;58:159-65.
23. Clements J, Mukhtar A. Tissue kallikrein and the bradykinin B2 receptor are expressed in endometrial and prostate cancers. Immunopharmacology 1997;36:217-20.
24. Hermann A, Arnhold M, Kresse H, Neth P, Fink E. Expression of components of the kallikrein-kinin system in human cell lines. Immunopharmacology 1999;45:135-9.
25. Matsukado K, Sugita M, Black KL. Intracarotid low dose bradykinin infusion selectively increases tumor permeability through activation of bradykinin B2 receptors in malignant gliomas. Brain Res 1998;792:10-5.
26. Raidoo DM, Sawant S, Mahabeer R, Bhoola K. Kinin receptors are expressed in human astrocytic tumour cells. Immunopharmacology 1999;43:255-63.
27. Dlamini Z, Raidoo D, Bhoola K. Visualisation of tissue kallikrein and kinin receptors in oesophageal carcinoma. Immunopharmacology 1999;43:303-10.
28. Hayashi I, Hoshiko S, Makabe O, Oh-ishi S. A point mutation of alanine 163 to threonine is responsible for the defective secretion of high molecular weight kininogen by the liver of brown Norway Katholiek rats. J Biol Chem 1993;268:17219-24.
29. Oh-Ishi S, Hayashi I, Hayashi M, et al. Evidence for a role of the plasma kallikrein-kinin system in acute inflammation: reduced exudation during carrageenin- and kaolin-pleurisies in kininogen-deficient rats. Agents Actions 1986;18:450-4.
30. Borkowski JA, Ransom RW, Seabrook GR, et al. Targeted disruption of a B2 bradykinin receptor gene in mice eliminates bradykinin action in smooth muscle and neurons. J Biol Chem 1995;270:13706-10.
31. Madeddu P, Emanueli C, Maestri R, et al. Angiotensin 11 type 1 receptor blockade prevents cardiac remodeling in bradykinin B(2) receptor knockout mice. Hypertension 2000;35:391-6.
32. Rohan RM, Fernandez A, Udagawa T, Yuan U, D'Amato RJ. Genetic heterogeneity of angiogenesis in mice. FASEB J 2000;14:871-6.
33. Majima M, Katori M, Hanazuka M, et al. Suppression of rat deoxycorticosterone-salt hypertension by kallikrein-kinin system. Hypertension 1991;17:806-13.
34. Ladoux A, Frelin C. Cobalt stimulates the expression of vascular endothelial growth factor mRNA in rat cardiac cells. Biochem Biophys Res Commun 1994;204:794-8.
35. Asano M, Inamura N, Hatori C, et al. The identification of an orally active, nonpeptide bradykinin B2 receptor antagonist, FR173657. Br J Pharmacol 1997;120:617-24.
36. Hock FJ, Wirth K, Albus U, et al. Hoe140 a new potent and long acting bradykinin-antagonist: in vitro studies. Br J Pharmacol 1991;102:769-73.
37. Wirth K, Breipohl G, Stechl S, Knolle J, Henke S, Scholkens B. DesArg9-D-Arg [Hyp3, Thi5, D-Tic7, Oic8] bradykinin (des Arg10-[Hoe140]) is a potent bradykinin B1 receptor antagonist. Eur Pharmacol 1991;205:217-8.
38. Majima M, Yoshida O, Mihara H, et al. High sensitivity to salt in kininogen-deficient brown Norway Katholiek rats. Hypertension 1993;22:705-14.
39. Haussant T, Michaud A, Bouhnik J, Savoie F, Alhene-Gelas F, Corvol P. Effect of dexamethasone on kininogen production by a rat hepatoma cell line. Biochem Biophys Res Commun 1988;154:1160-6.
40. Itoh N, Yokota S, Takagishi U. Hatta A, Okamoto H. Thiol proteinase inhibitor in the ascitic fluid of sarcoma 180 tumor-bearing mice. Cancer Res 1987;47:5560-5.
41. Ishihara K, Kamata M, Hayashi I, Yamashina S, Majima M. Roles of bradykinin in vascular permeability and angiogenesis in solid tumor. Int Immunopharmacol 2002;2:499-509.
42. Amano H, Ando K, Minamida S, et al. Adenylate cyclase/protein kinase A signaling pathway enhances angiogenesis through induction of vascular endothelial growth factor in vivo. Jpn J Pharmacol 2001;87:181-8.
43. Yoshida S, Amano H, Hayashi I, et al. COX-2/VEGF-dependent facilitation of tumor-associated angiogenesis and tumor growth in vivo. Lab Invest 2003;83:1385-94.
44. Katada J, Muramatsu M, Hayashi I, Tsutsumi M, Konishi Y, Majima M. Significance of vascular endothelial cell growth factor up-regulation mediated via a chymase-angiotensin-dependent pathway during angiogenesis in hamster sponge granulomas. J Pharmacol Exp Ther 2002;302:949-56.
45. Emanuell C, Minasi A, Zacheo A, et al. Local delivery of human tissue kallikrein gene accelerates spontaneous angiogenesis in mouse model of hindlimb ischemia. Circulation 2001;103:125-32.
46. Ferreira MA, Andrade SP, Pesquero JL, et al. Kallikrein-kinin system in the angiogenesis. Agents Actions 1992;38:165-74.
47. Majima M, Hayashi I, Muramatsu M, Katada J, Yamashina S, Katori M. Cyclo-oxygenase-2 enhances basic fibroblast growth factor-induced angiogenesis through induction of vascular endothelial growth factor in rat sponge implants. Br J Pharmacol 2000;130:641-9.
48. Naraba H, Ueno A, Yoshimura M, Kosugi Y, Oh-ishi S. Examination of signal transduction pathway of stimulated B1 and B2 kinin receptors; MAP kinase pathway to AP-1 translocation in HEK193 cells. Immunopharmacology 1999;45:35-8.
49. Hayashi R, Yamashita N, Matsui S, et al. Bradykinin stimulates IL-6 and IL-8 production by human lung fibroblasts through ERK- and p38 MAPK-dependent mechanisms. Eur Respir J 2000;16:452-8.
50. Waiden PD, Lefkowitz GK, Ittmann M, Lepor H, Monaco ME. Mitogenic activation of human prostate-derived fibromuscular stromal cells by bradykinin. Br J Pharmacol 1999;127:220-6.
51. Tischer E, Mitchell R, Hartman T, et al. The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing. J Biol Chem 1991;266:11947-54.